Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

2 Sep 2020 16:55

RNS Number : 8673X
Amati AIM VCT PLC
02 September 2020
Β 

Β 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Β 

Offer for Subscription of New Shares (the "Offer")

Β 

Amati AIM VCT plc announces an allotment on 2 September 2020 of 1,302,652 New Shares pursuant to the Offer. In accordance with the Terms and Conditions of the Offer, the Offer Price at which new ordinary shares were allotted, which was calculated by reference to the net asset value of an ordinary share on 31 August 2020, was 172.65p per ordinary share (net asset value divided by 0.99 to allow for issue costs of 1.0%).

Β 

Following the allotment above, the total number of ordinary shares in issue is 106,653,900 with each ordinary share carrying one voting right. That figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Β 

Applications have been made for the New Shares to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for admission to trading on the Main Market. It is expected that admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer on or around 8 September 2020. CREST accounts are expected to be credited within five business days of allotment and definitive documents of title are expected to be dispatched within ten business days of allotment.

Β 

Terms defined in the Prospectus published by the Company on 31 October 2019 have the same meanings in this announcement unless the context requires otherwise.

Β 

Β 

Β 

For further information please email info@amatiglobal.com.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEKKBBPPBKDNCK
Date   Source Headline
27th Nov 201711:30 amRNSDirector/PDMR Shareholding
27th Nov 201710:50 amRNSIssue of Equity
24th Nov 20172:28 pmRNSNet Asset Value(s)
23rd Nov 20173:25 pmRNSTransaction in Own Shares
21st Nov 201711:48 amRNSTransaction in Own Shares
21st Nov 20179:13 amRNSDirector/PDMR Shareholding
21st Nov 20178:37 amRNSIssue of Equity
17th Nov 20174:28 pmRNSNet Asset Value(s)
15th Nov 20173:35 pmRNSTransaction in Own Shares
13th Nov 20173:06 pmRNSNet Asset Value(s)
8th Nov 20172:48 pmRNSTransaction in Own Shares
8th Nov 20171:09 pmRNSTransaction in Own Shares - replacement
3rd Nov 201711:56 amRNSTransaction in Own Shares
2nd Nov 20175:13 pmRNSNet Asset Value(s)
1st Nov 20178:42 amRNSTotal Voting Rights
30th Oct 20172:16 pmRNSNet Asset Value(s)
30th Oct 201712:21 pmRNSTransaction in Own Shares
27th Oct 20174:54 pmRNSIssue of a Prospectus and Offers
20th Oct 20175:00 pmRNSNet Asset Value(s)
16th Oct 20175:28 pmRNSNet Asset Value(s)
13th Oct 20171:15 pmRNSTransaction in Own Shares
9th Oct 20174:10 pmRNSNet Asset Value(s)
5th Oct 20171:22 pmRNSTransaction in Own Shares
4th Oct 20177:49 amRNSDividend Declaration
3rd Oct 20171:28 pmRNSNet Asset Value(s)
2nd Oct 20178:28 amRNSTotal Voting Rights
29th Sep 20171:38 pmRNSTransaction in Own Shares
28th Sep 20175:05 pmRNSHalf-year Report
25th Sep 201712:27 pmRNSNet Asset Value(s)
22nd Sep 20172:00 pmRNSTransaction in Own Shares
18th Sep 201711:32 amRNSNet Asset Value(s)
15th Sep 20175:02 pmRNSTransaction in Own Shares
13th Sep 201711:22 amRNSTransaction in Own Shares
11th Sep 20174:05 pmRNSNet Asset Value(s)
11th Sep 201712:33 pmRNSTransaction in Own Shares
5th Sep 20174:36 pmRNSHolding(s) in Company
5th Sep 201710:18 amRNSNet Asset Value(s)
1st Sep 20179:30 amRNSTotal Voting Rights
30th Aug 201711:04 amRNSNet Asset Value(s)
25th Aug 20178:38 amRNSCompliance with MAR
23rd Aug 20174:59 pmRNSTransaction in Own Shares
21st Aug 20172:52 pmRNSNet Asset Value(s)
18th Aug 20179:19 amRNSTransaction in Own Shares
15th Aug 20178:07 amRNSNet Asset Value(s)
7th Aug 20175:14 pmRNSNet Asset Value(s)
2nd Aug 20171:21 pmRNSNet Asset Value(s)
1st Aug 20179:37 amRNSTotal Voting Rights
28th Jul 20172:36 pmRNSTransaction in Own Shares
26th Jul 20173:32 pmRNSTransaction in Own Shares
24th Jul 20178:51 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.